This comprehensive review examines the evolving landscape of clinical trial design for Advanced Therapy Medicinal Products (ATMPs), including cell and gene therapies.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on implementing Good Manufacturing Practice (GMP) for scalable stem cell biomanufacturing.
This article provides a detailed guide for researchers, scientists, and drug development professionals on the regulatory pathway for manufacturing cell therapies in the European Union.
This article provides a comprehensive analysis of current protocols for differentiating human induced pluripotent stem cells (iPSCs) into cardiomyocytes (iPSC-CMs).
This article provides a detailed, state-of-the-art overview of the autologous induced pluripotent stem cell (iPSC) therapy pipeline, tailored for researchers, scientists, and drug development professionals.
This article explores the integrated application of CRISPR-Cas9 gene editing and induced pluripotent stem cell (iPSC) technologies for disease correction and therapeutic development.
This article provides a comprehensive overview of mRNA-based technology for cell fate reprogramming, a transformative approach in regenerative medicine and drug development.
This article explores the transformative role of 3D bioprinting in fabricating complex, biomimetic tissue architectures for advanced biomedical applications.
This article provides a comprehensive analysis of the paracrine hypothesis in stem cell-based regenerative medicine.
This article provides a comprehensive overview of Integrative and Regenerative Pharmacology (IRP), an emerging interdisciplinary field that merges pharmacological sciences, systems biology, and regenerative medicine to develop transformative, curative therapies.